ABMD 32.95 Abiomed $ABMD Hit a 52 week high of 33.74

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
ABMD 32.95 Abiomed $ABMD Hit a 52 week high of 33.74 Closing the day 09:44 at 32.95 -0.65 -1.93% With a day low of 32.95 and a total volume of 22,639.

ABMD Recent Posts: http://investorshangout.com/Abiomed-ABMD-53201/

ABMD Abiomed Recent Headline News

ABIOMED (ABMD) Stock: Moving Average Crossover Alert - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 31 mins ago
ABIOMED (ABMD) Stock: Moving Average Crossover Alert
ABMD: 33.23 (-0.37)

Thoratec (THOR) Down to Strong Sell on Growing Headwinds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 12:20PM CST
On Nov 11, 2014, Zacks Investment Research downgraded Thoratec Corp. (THOR) to a Zacks Rank #5 (Strong Sell).
ABMD: 33.23 (-0.37), EW: 123.66 (+0.71), THOR: 28.20 (+0.28), ANGO: 17.01 (+0.03)

Abiomed (ABMD) Hits 52-Week High on Strong Q2 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 10:10AM CST
Shares of Abiomed, Inc. (ABMD) have been on the rise since it reported impressive second-quarter fiscal 2015 (ended Sep 30, 2014) results on Oct 30.
ABMD: 33.23 (-0.37), FLDM: 30.45 (+0.56), GMED: 23.23 (+0.07), ANGO: 17.01 (+0.03)

ABIOMED Shares Up 34.3% Since SmarTrend's Buy Recommendation (ABMD)
Comtex SmarTrend(R) - Wed Nov 12, 9:15AM CST
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on October 28th, 2014 at $24.67. In approximately 2 weeks, ABIOMED has returned 34.28% as of today's recent price of $33.13.
ABMD: 33.23 (-0.37)

Mettler-Toledo (MTD) Tops Q3 Earnings on Revenue Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 8:34AM CST
Mettler-Toledo International Inc. (MTD) reported adjusted earnings per share (EPS) of $2.95 for the third quarter of fiscal 2014, which beat the Zacks Consensus Estimate of $2.86. Adjusted EPS also improved 13% from the year-ago quarter.
ABMD: 33.23 (-0.37), FLDM: 30.45 (+0.56), ANGO: 17.01 (+0.03), MTD: 286.41 (+1.71)

Roka Bioscience (ROKA) in Focus: Stock Surges 19.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:11AM CST
Roka Bioscience, Inc. (ROKA) was a big mover last session, as the company saw its shares rise over 19% on the day.
ABMD: 33.23 (-0.37), ROKA: 3.50 (-0.09), EW: 123.66 (+0.71), ANGO: 17.01 (+0.03)

OTC Daily Alert Stock Watch - ABIOMED, Inc. (NASDAQ: ABMD)
WorldStockWire - Mon Nov 10, 12:30PM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
ABMD: 33.23 (-0.37)

Volcano Posts Narrower-than-Expected Q3 Loss, Guides Low - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:10AM CST
Despite Volcano (VOLC) provided disappointing revenue guidance for 2014 on account of expected negative foreign exchange impact, management expects accelerated profitability over the near term.
ABMD: 33.23 (-0.37), VOLC: 11.15 (+0.08), EW: 123.66 (+0.71), ANGO: 17.01 (+0.03)

Strength Seen in DexCom (DXCM): Stocks Gains 14.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:46AM CST
DexCom (DXCM) was a big mover last session, with shares rising over 14% on the day.
ABMD: 33.23 (-0.37), DXCM: 53.50 (-0.51), EW: 123.66 (+0.71), ANGO: 17.01 (+0.03)

VYCOR: "On the Cusp of the Next Big Healthcare Trend"
ACCESSWIRE - Mon Nov 10, 8:23AM CST
Vycor: "On the Cusp of the Next Big Healthcare Trend"
MDVN: 106.80 (+0.47), ABMD: 33.23 (-0.37), JNJ: 108.99 (+0.24), AMGN: 161.50 (-0.43), EXAS: 22.65 (+0.15), ARAY: 7.00 (-0.05), HOLX: 26.52 (-0.03), PBYI: 240.05 (+3.93)

Update: Abiomed's Q2 Fiscal 2015 Earnings Remained Impressive
Andy Batts - at Seeking Alpha - Sat Nov 08, 4:40PM CST

ABMD: 33.23 (-0.37)

Hologic Beats Q4 Earnings, Sales as All Segments Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 1:50PM CST
Hologic (HOLX) entered into an amended license agreement with Roka Bioscience, which earned a one-time revenue benefit of $20.1 million for Hologic
ABMD: 33.23 (-0.37), DXCM: 53.50 (-0.51), ANGO: 17.01 (+0.03), HOLX: 26.52 (-0.03)

Thoratec Q3 Earnings & Revenues Lag Estimates, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:00AM CST
Following the earnings release, shares of Thoratec Corp. (THOR) declined approximately 3.5% to close at $26.10 yesterday.
ABMD: 33.23 (-0.37), CYNO: 26.99 (-0.41), THOR: 28.20 (+0.28), ANGO: 17.01 (+0.03)

Abiomed (ABMD) Upgraded From Hold to Buy
at The Street - Fri Nov 07, 8:07AM CST
Abiomed (ABMD) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
ABMD: 33.23 (-0.37)

Foundation Medicine Slumps: FMI Tumbles 9.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:59AM CST
Foundation Medicine has been witnessing a flat trend in its current year earnings estimate and its share price has been falling for past 24 hours
ABMD: 33.23 (-0.37), DXCM: 53.50 (-0.51), FMI: 25.10 (unch), ANGO: 17.01 (+0.03)

Mindray Medical Q3 Earnings in Line, 2014 View Lowered - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:07PM CST
Mindray Medical International Limited (MR) slashed its 2014 financial guidance in the face of increasing uncertainties in currency and other macro developments that could impact its performance in certain key markets.
ABMD: 33.23 (-0.37), FLDM: 30.45 (+0.56), ANGO: 17.01 (+0.03), MR: 31.50 (+0.01)

Abiomed Tops Q2 Earnings, Revenues; FY15 Sales View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:10PM CST
Abiomed Inc. (ABMD) reported second-quarter fiscal 2015 earnings of 9 cents per share, outshining the Zacks Consensus Estimate of 2 cents.
ABMD: 33.23 (-0.37), FLDM: 30.45 (+0.56), BEAT: 8.50 (+0.23), ANGO: 17.01 (+0.03)

Downgrade Alert for ABIOMED (ABMD)
Comtex SmarTrend(R) - Mon Nov 03, 7:58AM CST
ABIOMED (NASDAQ:ABMD) was downgraded from Buy to Neutral at BTIG today. The stock closed yesterday at $32.79 on volume of 1.3 million shares, above average daily volume of 260,000. ABIOMED share prices have moved between a 52-week high of $32.99 and a 52-week low of $20.29 and closed yesterday at 62% above that low price at $32.79 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.1% while the 200-day MA has remained constant.
ABMD: 33.23 (-0.37)

Abiomed ups earnings 246% in FQ2
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 8:18AM CDT

ABMD: 33.23 (-0.37)

Nasdaq stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 31.30 (+0.63), ABMD: 33.23 (-0.37), BGFV: 13.37 (-0.01), RDCM: 9.11 (-0.19), AMED: 25.24 (+0.13), MRCY: 13.66 (+0.03), OMER: 19.59 (-0.12), ESBF: 19.30 (+0.03), EVOK: 6.33 (+0.03), IQNT: 18.87 (+0.25), KONA: 23.26 (+0.25), TQNT: 22.49 (+0.39), LAKE: 12.14 (-0.10), SAJA: 5.90 (-0.35)

Abiomed (ABMD) Stock Research Links

ABMD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tragedy Highlights Need for E-bike Safety Overhaul

Updated Category News Views 6

A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...

Continue Reading
Qatar Foundation Spurs Sport-Driven Empowerment Moves

Updated Category News Views 4

Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...

Continue Reading
Why Liver Nurture Taps into Health Sector Trends

Updated Category News Views 5

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Continue Reading
USPS Rolls Out Christmas Cookie Stamps Nationwide

Updated Category News Views 5

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Continue Reading
Papa John's Faces Class Action Over Misleading Info

Updated Category News Views 5

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

Continue Reading
Med Spa Visits: Key Insights from Lindsey Smith

Updated Category News Views 4

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 9

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 7

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading
BarrelPick.com Launches for Bourbon Aficionados

Updated Category News Views 4

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Continue Reading

Top 5 Most Recently Viewed Articles

The Remarkable Growth of GE Aero: A Five-Year Journey

Updated Category News Views 157

An Insightful Look at GE Aero's Growth GE Aero has truly excelled in the market over the past five years. With an impressive annualized return of 31.75%, it has outperformed many competitors, making it an intriguing option for investors. As of now, GE Aero boasts a market capitalization of around $193.98 billion. The Impact of $100 Investment Imagine investing $100 in GE...

Continue Reading
Exploring Growth Trends in the Single-Cell Biotherapeutics Sector

Updated Category News Views 137

Understanding the Single-Cell Biotherapeutics Market The single-cell biotherapeutics market is currently under significant transformation, reflecting an upward trajectory supported by various factors. This burgeoning market is on pace to generate substantial revenue, driven largely by consumer preferences and rapid technological developments that are reshaping the...

Continue Reading
Top Solar Stocks to Consider for Growth in the Coming Years

Updated Category News Views 139

Understanding the Solar Energy Landscape The U.S. energy infrastructure faces transformative changes. Despite recent regulatory actions favoring gas, oil, nuclear, and geothermal energy, the solar sector continues to thrive. Presently, solar energy accounts for 7% of the national electric grid capacity, equating to approximately 220 GW. According to reports, a significant...

Continue Reading
DFS Memorials Partners with Canadian Funerals for Affordable Cremation

Updated Category News Views 195

DFS Memorials and Canadian Funerals Online Unite for Affordable Services DFS Memorials, a respected network that connects families to local, licensed funeral homes providing low-cost direct cremation services, is proud to announce its partnership with Canadian Funerals Online. This collaboration is a significant step towards improving access to affordable cremation...

Continue Reading
SYNO International Expands Global Reach Through Strategic Alliances

Updated Category News Views 148

Strategic Growth: SYNO International's Collaborative Path Recently, SYNO International (SNI) made significant strides in its global outreach by co-hosting a pivotal summit that connected international investors with Indonesian economic opportunities. This event was a defining moment for SNI, highlighting its commitment not just to investment but to building lasting...

Continue Reading